Zhejiang CONBA Pharmaceutical Co., Ltd.SSE: 600572

Announcement on Implementation of Dividend Distribution for 2025

Jun 17, 2026 · Issued by Zhejiang CONBA Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jun 17, 2026

On 6ix: 6ix.com/news/announcement-on-implementation-of-dividend-distribution-for-2025-69

Announcement on Implementation of Dividend Distribution for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Zhejiang CONBA Pharmaceutical Co., Ltd. on 6ix

Earlier from Zhejiang CONBA Pharmaceutical

Announcement on the Public Listing and Transfer of 100% Equity Interest in Dongyang ConbaJun 9
Announcement on Convening Performance Briefing for 2025 and Q1 2026Jun 6
Announcement on Resolutions of the 2025 Annual General MeetingMay 14
Announcement on Obtaining Drug Registration Certificate for Blonanserin Tablets by its SubsidiaryMay 9
Report for Q1 2026Apr 23

Later from Zhejiang CONBA Pharmaceutical

Announcement on Resolutions of the 18th (Extraordinary) Meeting of the 11th Board of DirectorsJun 18
Announcement on Self-exercise Results of Stock Option Incentive Plan and Share Changes for Q2 2026Jul 2
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026Jul 4
Announcement on the Execution of the License, Development and Commercialization Agreement for Cebranopadol in Greater China by Subsidiaries Hangzhou CONBA and Hong Kong CONBA with AdneurisJul 7
Announcement on Inclusion of Products of the Company and Its Subsidiaries in the "National Essential Medicines List (2026 Edition)"Jul 11

All Zhejiang CONBA Pharmaceutical news releases

Follow Zhejiang CONBA Pharmaceutical into a list and get an email when it puts out news.

Follow Zhejiang CONBA Pharmaceutical